BoneSupport AB is a Swedish biotech company active at the Ideon Science Park in the university town of Lund in Skåne, Sweden, founded in 1999 by Lars Lidgren, Professor of Orthopedic Surgery and Academic Head of Department at Lund University Hospital in Sweden which is a member of the ISOC group of orthopaedic centers.
[2][3] Cerament is used for the treatment of fragility fractures caused by Osteoporosis, to fill bone voids or gaps caused by trauma or orthopedic surgical procedures for e.g., benign tumors, and for augmentation of fracture repair.
In September 2012, BoneSupport entered a distribution agreement with the major medical device manufacturer Biomet who have exclusive distribution rights of the Cerament bone void filler product range in the United States of America and Canada.
This agreement is expected to accelerate the usage of Bonesupport's bone void filler (Cerament) product line in orthopaedic operations.
On 11 June 2017, BoneSupport AB's Board of Directors applied for the company's shares to be admitted to trading on Nasdaq Stockholm's main market.